TrueMark Investments LLC Takes $6.88 Million Position in CME Group Inc. (NASDAQ:CME)

TrueMark Investments LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,916 shares of the financial services provider's stock, valued at approximately $6,875,000. CME Group accounts for about 1.8% of TrueMark Investments LLC's portfolio, making the stock its 8th biggest holding.

Several other large investors have also made changes to their positions in the company. Bank Pictet & Cie Europe AG increased its holdings in CME Group by 29.0% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock valued at $20,190,000 after purchasing an additional 19,533 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in CME Group by 12.1% in the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock valued at $101,000 after purchasing an additional 47 shares during the last quarter. Atria Wealth Solutions Inc. increased its holdings in CME Group by 13.8% in the fourth quarter. Atria Wealth Solutions Inc. now owns 4,314 shares of the financial services provider's stock valued at $1,025,000 after purchasing an additional 524 shares during the last quarter. Private Advisor Group LLC increased its holdings in CME Group by 7.9% in the fourth quarter. Private Advisor Group LLC now owns 7,000 shares of the financial services provider's stock valued at $1,626,000 after purchasing an additional 512 shares during the last quarter. Finally, Townsend & Associates Inc increased its holdings in CME Group by 2.1% in the fourth quarter. Townsend & Associates Inc now owns 77,157 shares of the financial services provider's stock valued at $17,920,000 after purchasing an additional 1,571 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Activity at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of the stock in a transaction that occurred on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the transaction, the director now directly owns 38,651 shares of the company's stock, valued at approximately $10,207,729.10. This represents a 4.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 500 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director now directly owns 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,400 shares of company stock valued at $3,680,610. Insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent analyst reports. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Oppenheimer increased their price target on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Royal Bank Of Canada restated a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Bank of America increased their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Finally, Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 23rd. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $258.20.

CME Group Stock Up 0.7%

CME stock opened at $273.99 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $98.74 billion, a P/E ratio of 27.56, a P/E/G ratio of 3.72 and a beta of 0.45. The business has a 50-day moving average of $274.17 and a 200-day moving average of $255.58. CME Group Inc. has a fifty-two week low of $192.11 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.50 earnings per share. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.